Theravance Biopharma Inc.

AI Score

XX

Unlock

8.52
0.20 (2.40%)
At close: Apr 09, 2025, 3:59 PM
8.43
-1.08%
Pre-market: Apr 10, 2025, 08:38 AM EDT

Theravance Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
64.38M 57.42M 51.35M 55.31M 71.86M 73.41M 60.37M 15.39M 48.65M
n/a 40.62M 6.59M 7.29M 260.95M 219.25M 715K 6.03M 2.89M
64.38M 16.8M 44.76M 48.02M -189.1M -145.83M 59.66M 9.36M 45.75M
-46.95M -56.03M -91.96M -257.78M -297.76M -251.91M -238.75M -260.12M -180.47M
4.88M 9.12M 8.54M 1.11M 2.83M 8.39M 11.97M 4.96M 1.31M
-44.61M -49.27M -92.81M -199.58M -286.54M -241.68M -226.09M -271.71M -180.56M
-56.42M -55.19M -92.82M -199.43M -278.02M -236.46M -215.52M -285.4M -190.67M
69.17M 70.09M 67.07M 99.3M 108.66M 106.08M 97.06M 95.59M 84.51M
37.64M 40.62M 63.39M 193.66M 260.95M 219.25M 201.35M 173.89M 141.71M
4.51M n/a n/a n/a -1.61M n/a n/a n/a n/a
111.33M 113.46M 130.47M 292.95M 369.61M 325.33M 298.41M 269.48M 226.22M
2.55M 2.35M 6.37M 46.89M 44.59M 31.86M 10.48M 8.55M 1.4M
n/a 5.1M 8M n/a n/a n/a n/a n/a n/a
111.33M 113.46M 130.47M 292.95M 369.61M 325.33M 299.12M 275.51M 229.12M
11.8M 5.92M 9K -151K -8.52M -5.22M -10.56M 13.69M 10.11M
48.85M 55.3M 73.59M 69.46M 62.34M 55.61M 53.97M 52.35M 44.71M
48.85M 55.3M 73.59M 69.46M 62.34M 55.61M 53.97M 52.35M 44.71M
-1.15 -1 -1.26 -2.87 -4.46 -4.25 -3.99 -5.45 -4.26
-1.15 -1 -1.26 -2.87 -4.46 -4.25 -3.99 -5.45 -4.26
-46.95M -40.87M -79.86M -249.39M -294M -203.29M -212.44M -259.14M -176.04M
-47.16M -46.92M -86.45M -256.68M -294.8M -209.81M -215.6M -263.16M -179.16M
211K 6.05M 6.59M 7.29M 6.64M 6.52M 3.17M 4.03M 3.12M